Adamas Pharmaceuticals Inc (ADMS)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Gregory T. Went
Employees:
159
1900 POWELL ST., SUITE 750, EMERYVILLE, CA 94608
510-450-3554

Adamas Pharmaceuticals, Inc. operates as a pharmaceutical company, which engages in discovering chrono-synchronous therapies. It involves in the development and commercialization of therapeutics targeting chronic disorders of the central nervous system. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA.

Data derived from most recent annual or quarterly report
Market Cap 374.798 Million Shares Outstanding45.596 Million Avg 30-day Volume 827.831 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.63
Price to Revenue2.7488 Debt to Equity21.8526 EBITDA-39.924 Million
Price to Book Value36.712 Operating Margin-51.1798 Enterprise Value220.262 Million
Current Ratio5.419 EPS Growth0.456 Quick Ratio4.704
1 Yr BETA 52-week High/Low 9.15 / 4.02 Profit Margin-67.2561
Operating Cash Flow Growth29.4357 Altman Z-Score-2.8916 Free Cash Flow to Firm -38.485 Million
View SEC Filings from ADMS instead.

View recent insider trading info

Funds Holding ADMS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ADMS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DEMSKI MARTHA J

  • Director
0 2021-11-24 3

RICHO ANNA

  • Director
0 2021-11-24 2

BIGHAM MICHAEL

  • Director
0 2021-11-24 2

MAHONEY DAVID L

  • Director
0 2021-11-24 3

MACPHEE JOHN A

  • Director
0 2021-11-24 3

ERICSON WILLIAM W.

  • Director
  • 10% Owner
0 2021-11-24 2

MCFARLANE NEIL F. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2021-11-24 2

PRENTISS CHRISTOPHER B CHIEF FINANCIAL OFFICER

  • Officer
0 2021-11-24 5

SHREEDHAR VIJAY CHIEF COMMERCIAL OFFICER

  • Officer
0 2021-11-24 5

PAPAPETROPOULOS SPYRIDON

  • Director
0 2021-11-24 3

DIER MARDI

  • Director
20,000 2021-06-02 1

LIEBERBURG IVAN M

  • Director
69,000 2020-06-03 0

MERRIWEATHER ALFRED G CHIEF FINANCIAL OFFICER

  • Officer
48,019 2019-09-20 0

RHODES JENNIFER J CBO, GC & COMPLIANCE OFFICER

  • Officer
63,114 2019-06-20 0

WENT GREGORY T CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
431,783 2019-04-08 0

PATNI RAJIV CHIEF MEDICAL OFFICER

  • Officer
49,141 2019-04-08 0

KING RICHARD CHIEF OPERATING OFFICER

  • Officer
48,856 2018-06-21 0

GREAT POINT PARTNERS LLC

JAY JEFFREY R

KROIN DAVID

  • 10% Owner
No longer subject to file 2017-06-19 0

BOOTH RICHARD H

  • Director
0 2017-06-01 0

DAWSON WILLIAM J CHIEF FINANCIAL OFFICER

  • Officer
14,284 2017-03-21 0

MDV IX LP

SEVENTH MDV PARTNERS, L.L.C.

NINTH MDV PARTNERS, L.L.C.

FEIBER JONATHAN D

SCHOENDORF NANCY J

MDV ENF VII (A), L.P.

MDV ENF VII (B), L.P.

MDV VII LEADERS' FUND, L.P.

MDV VII LP

  • 10% Owner
4,619,796 2016-09-14 0

MCCLURE NATALIE SVP, PRODUCT DEVELOPMENT

  • Officer
8,340 2016-04-18 0

LEWIS SARA GROOTWASSINK

  • Director
0 2015-05-14 0

AERIS CAPITAL EQUITY INVESTMENTS, L.P.

  • 10% Owner
1,662,128 2015-03-13 0

KNAPP JEFFREY H CHIEF OPERATING OFFICER

  • Officer
0 2015-02-25 0

SHIN GRACE GENERAL COUNSEL

  • Officer
0 2014-12-01 0

DAG VENTURES MANAGEMENT III, LLC

DAG VENTURES III-QP LP

DAG VENTURES III, L.P.

DAG VENTURES GP FUND III, LLC

CADEDDU JOHN J.

GOODRICH R. THOMAS

  • 10% Owner
1,660,229 2014-04-15 0

MDV IX LP

NINTH MDV PARTNERS, L.L.C.

FEIBER JONATHAN D

MDV VII LP

SEVENTH MDV PARTNERS, L.L.C.

SCHOENDORF NANCY J

  • 10% Owner
2,742,702 2014-04-09 0

COFFEE MICHAEL DENIS SENIOR VP, STRATEGY & PLANNING

  • Officer
0 2014-04-09 0

RIMAC ANTHONY M CHIEF FINANCIAL OFFICER

  • Officer
0 2014-04-09 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

ERICSON WILLIAM W. - Director - > 10% Owner

2021-11-24 16:09:56 -0500 2021-11-24 D 10,000 d 0 direct

RICHO ANNA - Director

2021-11-24 16:08:47 -0500 2021-11-24 U 25,000 d 0 direct

ERICSON WILLIAM W. - Director - > 10% Owner mdv vii, l.p.

2021-11-24 16:09:56 -0500 2021-11-24 U 265,150 d 0 indirect

ERICSON WILLIAM W. - Director - > 10% Owner mdv enf vii (b), l.p.

2021-11-24 16:09:56 -0500 2021-11-24 U 3,146 d 0 indirect

ERICSON WILLIAM W. - Director - > 10% Owner

2021-11-24 16:09:56 -0500 2021-11-24 U 10,000 d 0 direct

MAHONEY DAVID L - Director

2021-11-24 16:11:16 -0500 2021-11-24 D 40,000 d 0 direct

MAHONEY DAVID L - Director

2021-11-24 16:11:16 -0500 2021-11-24 U 5,000 d 0 direct

SHREEDHAR VIJAY - Officer CHIEF COMMERCIAL OFFICER

2021-11-24 16:09:36 -0500 2021-11-24 D 137,500 d 0 direct

BIGHAM MICHAEL - Director

2021-11-24 16:11:37 -0500 2021-11-24 D 10,000 d 0 direct

PAPAPETROPOULOS SPYRIDON - Director

2021-11-24 16:09:09 -0500 2021-11-24 D 10,000 d 0 direct

MACPHEE JOHN A - Director

2021-11-24 16:07:50 -0500 2021-11-24 D 10,000 d 0 direct

PRENTISS CHRISTOPHER B - Officer CHIEF FINANCIAL OFFICER

2021-11-24 16:10:18 -0500 2021-11-24 D 50,000 d 0 direct

MACPHEE JOHN A - Director

2021-11-24 16:07:50 -0500 2021-11-24 U 202,000 d 0 direct

PRENTISS CHRISTOPHER B - Officer CHIEF FINANCIAL OFFICER

2021-11-24 16:10:18 -0500 2021-11-24 A 18,750 a 163,767 direct

DEMSKI MARTHA J - Director

2021-11-24 16:08:14 -0500 2021-11-24 D 10,000 d 0 direct

MCFARLANE NEIL F. - Director - Officer CHIEF EXECUTIVE OFFICER

2021-11-24 16:10:40 -0500 2021-11-24 U 600,000 d 0 direct

RICHO ANNA - Director

2021-11-24 16:08:47 -0500 2021-11-24 D 10,000 d 0 direct

ERICSON WILLIAM W. - Director - > 10% Owner

2021-11-24 16:09:56 -0500 2021-11-24 D 10,000 d 0 direct

ERICSON WILLIAM W. - Director - > 10% Owner mdv ix, l.p., as nominee for mdv ix, l.p., and mdv enf ix, l.p.

2021-11-24 16:09:56 -0500 2021-11-24 U 287,992 d 0 indirect

ERICSON WILLIAM W. - Director - > 10% Owner mdv enf vii (a), l.p.

2021-11-24 16:09:56 -0500 2021-11-24 U 6,043 d 0 indirect

MAHONEY DAVID L - Director

2021-11-24 16:11:16 -0500 2021-11-24 D 10,000 d 0 direct

MAHONEY DAVID L - Director

2021-11-24 16:11:16 -0500 2021-11-24 D 10,000 d 0 direct

BIGHAM MICHAEL - Director

2021-11-24 16:11:37 -0500 2021-11-24 D 10,000 d 0 direct

SHREEDHAR VIJAY - Officer CHIEF COMMERCIAL OFFICER

2021-11-24 16:09:36 -0500 2021-11-24 U 186,786 d 0 direct

BIGHAM MICHAEL - Director

2021-11-24 16:11:37 -0500 2021-11-24 U 10,000 d 0 direct

PAPAPETROPOULOS SPYRIDON - Director

2021-11-24 16:09:09 -0500 2021-11-24 D 20,000 d 0 direct

MACPHEE JOHN A - Director

2021-11-24 16:07:50 -0500 2021-11-24 D 10,000 d 0 direct

PRENTISS CHRISTOPHER B - Officer CHIEF FINANCIAL OFFICER

2021-11-24 16:10:18 -0500 2021-11-24 D 37,500 d 0 direct

DEMSKI MARTHA J - Director

2021-11-24 16:08:14 -0500 2021-11-24 D 10,000 d 0 direct

MCFARLANE NEIL F. - Director - Officer CHIEF EXECUTIVE OFFICER

2021-11-24 16:10:40 -0500 2021-11-24 D 200,000 d 0 direct

DEMSKI MARTHA J - Director

2021-11-24 16:08:14 -0500 2021-11-24 U 5,000 d 0 direct

MCFARLANE NEIL F. - Director - Officer CHIEF EXECUTIVE OFFICER

2021-11-24 16:10:40 -0500 2021-11-24 A 75,000 a 600,000 direct

RICHO ANNA - Director

2021-11-24 16:08:47 -0500 2021-11-24 D 20,000 d 0 direct

ERICSON WILLIAM W. - Director - > 10% Owner

2021-11-24 16:09:56 -0500 2021-11-24 D 10,000 d 0 direct

ERICSON WILLIAM W. - Director - > 10% Owner mdv vii leaders' fund, l.p.

2021-11-24 16:09:56 -0500 2021-11-24 U 25,661 d 0 indirect

ERICSON WILLIAM W. - Director - > 10% Owner mdv vii lp, nom for mdv vii lp, mdv vii leaders' fund lp, mdv enf vii (a) lp, and mdv enf vii (b) lp

2021-11-24 16:09:56 -0500 2021-11-24 U 4,031,804 d 0 indirect

MAHONEY DAVID L - Director

2021-11-24 16:11:16 -0500 2021-11-24 D 10,000 d 0 direct

MAHONEY DAVID L - Director david l. mahoney & winnifred c. ellis 1998 family trust

2021-11-24 16:11:16 -0500 2021-11-24 U 112,781 d 0 indirect

SHREEDHAR VIJAY - Officer CHIEF COMMERCIAL OFFICER

2021-11-24 16:09:36 -0500 2021-11-24 D 47,500 d 0 direct

BIGHAM MICHAEL - Director

2021-11-24 16:11:37 -0500 2021-11-24 D 10,000 d 0 direct

SHREEDHAR VIJAY - Officer CHIEF COMMERCIAL OFFICER

2021-11-24 16:09:36 -0500 2021-11-24 A 18,750 a 186,786 direct

MACPHEE JOHN A - Director

2021-11-24 16:07:50 -0500 2021-11-24 D 10,000 d 0 direct

PAPAPETROPOULOS SPYRIDON - Director

2021-11-24 16:09:09 -0500 2021-11-24 U 20,975 d 0 direct

MACPHEE JOHN A - Director

2021-11-24 16:07:50 -0500 2021-11-24 D 24,000 d 0 direct

PRENTISS CHRISTOPHER B - Officer CHIEF FINANCIAL OFFICER

2021-11-24 16:10:18 -0500 2021-11-24 U 163,767 d 0 direct

DEMSKI MARTHA J - Director

2021-11-24 16:08:14 -0500 2021-11-24 D 10,000 d 0 direct

MCFARLANE NEIL F. - Director - Officer CHIEF EXECUTIVE OFFICER

2021-11-24 16:10:40 -0500 2021-11-24 D 250,000 d 0 direct

DEMSKI MARTHA J - Director martha j. demski u/d/t 10/1/1994, martha j. demski trustee

2021-11-24 16:08:14 -0500 2021-11-24 U 16,000 d 0 indirect

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 22:15:03 UTC -0.4667 0.5367 650000
ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 21:45:03 UTC -0.4667 0.5367 650000
ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 21:15:03 UTC -0.4667 0.5367 650000
ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 20:45:03 UTC -0.4667 0.5367 650000
ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 20:15:03 UTC -0.4667 0.5367 650000
ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 19:45:03 UTC -0.4667 0.5367 650000
ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 19:15:03 UTC -0.4667 0.5367 650000
ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 18:45:03 UTC -0.4667 0.5367 650000
ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 18:15:04 UTC -0.4667 0.5367 650000
ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 17:45:03 UTC -0.4667 0.5367 650000
ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 17:15:03 UTC -0.4667 0.5367 650000
ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 16:45:03 UTC -0.4667 0.5367 650000
ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 16:15:03 UTC -0.4667 0.5367 650000
ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 15:45:03 UTC -0.4667 0.5367 650000
ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 15:15:03 UTC -0.4667 0.5367 650000
ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 14:45:03 UTC -0.4139 0.4839 650000
ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 14:15:03 UTC -0.4139 0.4839 650000
ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 13:45:03 UTC -0.4139 0.4839 650000
ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 13:15:03 UTC -0.4139 0.4839 650000
ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 12:45:03 UTC -0.4139 0.4839 650000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments